Diphtheria, Tetanus, Pertussis (Whole Cell) and Haemophilus Type b Conjugate Vaccine (Adsorbed) I.P.

This quadrivalent vaccine combines protection against diphtheria, tetanus, pertussis (whooping cough), and Haemophilus influenzae type b (Hib). It is part of the standard childhood immunization schedule and is especially important in early infancy when vulnerability to these infections is highest. The vaccine uses whole-cell pertussis and conjugated Hib components to induce strong and lasting immunity. It helps reduce disease burden and supports herd immunity. By combining multiple antigens, this vaccine lessens the number of injections required, promoting greater adherence to vaccination schedules and improving overall public health outcomes.